Study Detail

TitleHCV NS5A sequencing
Study TypeOther
Abstract Recent advances in interferon-free treatment could lead to the eradication of HCV from patients infected with HCV. One of the direct-acting anti-viral agents, HCV NS5A inhibitor is available for these combination therapies. However, naturally occurring resistance-associated variants (RAVs) to HCV NS .. [more]
Description Recent advances in interferon-free treatment could lead to the eradication of HCV from patients infected with HCV. One of the direct-acting anti-viral agents, HCV NS5A inhibitor is available for these combination therapies. However, naturally occurring resistance-associated variants (RAVs) to HCV NS .. [more]
Center NameYCH